Plasma levobunolol levels following topical administration with reference to systemic side effects
- PMID: 3306546
- DOI: 10.1159/000309765
Plasma levobunolol levels following topical administration with reference to systemic side effects
Abstract
We determined the plasma level of levobunolol in normal volunteers after a single topical instillation of 0.5 or 1% levobunolol in both eyes, and after twice-daily instillations for 1 week. Levobunolol levels were detected within 1 h following acute instillation. During the study, mean plasma levels ranged from 0.1 to 0.3 ng/ml for the 0.5% group and 0.3 to 0.6 ng/ml for the 1% group. The highest individual plasma level was 1.2 ng/ml, which occurred in 1 patient receiving 1% levobunolol. After 1 week of twice-daily instillation mean plasma levels were similar to those observed after acute instillation. Minimal cardiovascular changes were observed in the 0.5% group while decreases in heart rate and systolic blood pressure were observed in the 1% treatment group.
Similar articles
-
Glaucoma treatment with once-daily levobunolol.Am J Ophthalmol. 1986 Mar 15;101(3):298-304. doi: 10.1016/0002-9394(86)90823-8. Am J Ophthalmol. 1986. PMID: 3513594 Clinical Trial.
-
Effect of varying drop size on the efficacy and safety of a topical beta blocker.Ann Ophthalmol. 1989 Sep;21(9):351-7. Ann Ophthalmol. 1989. PMID: 2683937 Clinical Trial.
-
Efficacy and safety of once-daily levobunolol for glaucoma therapy.Can J Ophthalmol. 1989 Feb;24(1):2-6. Can J Ophthalmol. 1989. PMID: 2653592 Clinical Trial.
-
Levobunolol for the long-term treatment of glaucoma.Gen Pharmacol. 1986;17(4):373-7. doi: 10.1016/0306-3623(86)90177-1. Gen Pharmacol. 1986. PMID: 3019819 Review.
-
Comparison of ophthalmic beta-blocking agents.Clin Pharm. 1987 Jun;6(6):451-63. Clin Pharm. 1987. PMID: 2891463 Review.
Cited by
-
Intraocular administration of tetramethylpyrazine hydrochloride to rats: a direct delivery pathway for brain targeting?Drug Deliv. 2019 Dec;26(1):841-848. doi: 10.1080/10717544.2019.1650849. Drug Deliv. 2019. PMID: 31401891 Free PMC article.
-
Ocular levobunolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1987 Dec;34(6):648-61. doi: 10.2165/00003495-198734060-00002. Drugs. 1987. PMID: 2892662 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources